Financing type:  underwritten prospectus offering

Gross proceeds:  $61,613,440 (U.S.)

Offering:  18,121,600 listed shares

Offering price:  $3.40 (U.S.) (approximately $4.65 (Canadian)) per listed share

Overallotment option:  The underwriters may purchase a maximum of 1,941,600 listed shares for overallotment purposes. As of Feb. 12, 2026, 1,941,600 listed shares have been issued thereunder. All information presented herein includes such exercise.

Disclosure:  Refer to the prospectus supplement dated Feb. 4, 2026, and the company's news release dated Feb. 9, 2026.